Lv7
3310 积分 2023-07-09 加入
The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure
10天前
已完结
PDE8 Inhibition and Its Impact on I Ca,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target
11天前
已完结
Recent Advances in Inflammation & Allergy Drug Discovery
11天前
已关闭
New pharmacologic interventions to increase cardiac contractility
13天前
已完结
Milrinone in Advanced Heart Failure: Current Evidence, Clinical Applications, and Future Directions
13天前
已完结
Myocardial Phosphodiesterases and Their Role in cGMP Regulation
14天前
已完结
Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
24天前
已完结
Quantitative Phosphoproteomics to Study cAMP Signaling
24天前
已完结
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension
24天前
已完结
皖公网安备34019202002308
